Download or read book AURYXIA Drug Profile 2023 written by DrugPatentWatch and published by DrugPatentWatch.com. This book was released on 2023-08-15 with total page 77 pages. Available in PDF, EPUB and Kindle. Book excerpt:

AURYXIA Drug Profile, 2023

This report focuses on AURYXIA and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• Clinical trials
• Drug prices
• Raw active pharmaceutical ingredient (API) sources

Download or read book The APRN and PA s Complete Guide to Prescribing Drug Therapy 2022 written by Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE and published by Springer Publishing Company. This book was released on 2021-07-06 with total page 1019 pages. Available in PDF, EPUB and Kindle. Book excerpt: Includes 25 new diagnoses and digital updates as needed! The only prescribing guide conveniently organized by clinical diagnoses for adult and pediatric patients, this concise resource is an unrivaled reference tool for advanced health care providers (AHCPs) and students in all clinical practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Newly updated for 2022 with the most recent drug information and clinical guidance, this revised edition contains 25 new diagnoses including 15 additional cancer diagnoses and the novel Coronavirus (COVID-19). The APRN and PA's Complete Guide to Prescribing Drug Therapy 2022 intersperses clinically useful information throughout, such as monitored laboratory values, patient teaching points, and safety information. Section I alphabetically presents pharmacotherapy regimens for more than 600 clinical diagnoses. Each diagnosis contains drug choices alphabetically by generic name, FDA pregnancy category, OTC availability, generic availability, adult and pediatric dosing regimens, brand/trade names, available dose forms, and additive information. Section II uses a convenient table format to convey pediatric and adult immunization schedules, contraceptives, pediatric dosing tables for liquid anti infectives, and much more. An alphabetical cross reference index of drugs by generic and brand/trade names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and relative safety during pregnancy. Key Features: Uniquely organized by clinical diagnosis! Addresses drug treatment options for over 600 specific diagnoses Guides the AHCP through drug classes, categories, and brand/trade names for primary care health issues Contains over 30 Appendices with quick access to drugs by category (e.g., antineoplastics, anticonvulsants), child and adult immunization schedules, contraceptives by form, glucocorticosteroids by potency, and much more! Index provides cross referencing of drugs by generic and brand/trade names Includes eBook and regular updates with purchase of print guide

Download or read book Mosby s Dental Drug Reference E BOOK written by Arthur H. Jeske and published by Elsevier Health Sciences. This book was released on 2024-09-20 with total page 1435 pages. Available in PDF, EPUB and Kindle. Book excerpt: No dental office should be without this quick-reference drug handbook! Ideal for chairside use by the entire dental team, Mosby's Dental Drug Reference, 14th Edition, provides guidelines for safe, accurate drug administration. More than 800 drug monographs — including 93 new monographs covering newly released, FDA-approved drugs — make it easy to find the information most relevant to oral healthcare practitioners, including indications and dosages, contraindications, interactions, side effects, serious reactions, and dental-specific drug data. Accompanied by an Evolve website with additional monographs, photos of pathologic conditions, and more, this durable, pocket-sized guide provides the current, concise drug information needed at the point of care.

Download or read book The APRN and PA s Complete Guide to Prescribing Drug Therapy 2020 written by Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE and published by Springer Publishing Company. This book was released on 2019-05-09 with total page 778 pages. Available in PDF, EPUB and Kindle. Book excerpt: Includes more than 30 new diagnoses and eBook with digital updates as needed! Updated to deliver the most current standards, this is a unique prescribing reference for APRN students and advanced health care providers in all practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Concise, easy to read, and updated throughout, the resource delivers pharmacotherapy regimens for more than 600 diagnoses—including over 30 that are new. The print format includes an eBook with digital updates to assure immediate access to essential information. Listed alphabetically by diagnosis, pharmacotherapy regimens include, for each diagnosis, drug choices listed by generic name, FDA pregnancy category, generic/over-the-counter availability, adult/pediatric dosing regimens, brand names, forms of dosage, and additives. Clinically useful information such as laboratory values to be monitored, patient teaching points, and safety information is interspersed throughout each diagnosis. Additional quick-access features include information presented in convenient table format and an alphabetical cross-reference index of drugs by generic and brand name, with FDA pregnancy category and controlled drug schedule (I, II, III, IV, V). Key Features: Includes 31 new diagnoses totaling over 600 organized alphabetically Serves as a quick-access prescribing reference for APRN and PA students and health care providers in all primary care settings Presents drug information in condensed and summary form for ease of use Within each diagnosis, drug choices are listed alphabetically by generic /trade name, FDA pregnancy category, adult/pediatric dosing, dose forms, and additives Delivers guidance on lab values to be monitored, patient education points, and safety information Includes 30 Appendices with ready access to key drug classifications, FDA Pregnancy Categories, US Schedule of Controlled Substances, Immunization Schedules, Contraceptive Guidance, categories Anti-Infectives, and more! Offers brand/generic cross-reference

Download or read book EDURANT Drug Profile 2023 written by DrugPatentWatch and published by DrugPatentWatch.com. This book was released on 2023-08-15 with total page 100 pages. Available in PDF, EPUB and Kindle. Book excerpt:

EDURANT Drug Profile, 2023

This report focuses on EDURANT and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

Download or read book The APRN s Complete Guide to Prescribing Drug Therapy 2019 written by Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE and published by Springer Publishing Company. This book was released on 2018-04-28 with total page 857 pages. Available in PDF, EPUB and Kindle. Book excerpt: A quick-access guide to current drug recommendations with regular digital updates! Written for APRN students and practitioners who prescribe drugs for acute, episodic, and chronic health problems, this unique reference comes with an ebook and regular digital updates. It provides state-of-the-art guidance about appropriate pharmacotherapy options and treatment regimens for over 500 diagnoses in a concise, easy-to-use format. Comments deliver such useful information as laboratory values to monitor, patient teaching points, and safety information. To facilitate access to vital information, the guide presents clinical diagnoses alphabetically. Within each diagnosis, appropriate drug choices are listed by generic name, with FDA pregnancy category, generic or over-the-counter availability, adult/pediatric dosing regimens, brand names, dose forms, and information regarding additives. Thirty appendices provide quick access to key drug classifications, FDA Pregnancy Categories, U.S. Schedule of Controlled Substances, Immunization Schedules, and much more. An alphabetical cross-referenced index of drugs by generic and brand names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and safety during pregnancy. KEY FEATURES: Presents information in concise format for speedy drug information retrieval Organized alphabetically by over 500 diagnoses Lists drug choices by generic name, FDA pregnancy category, availability of generic and trade forms, adult/pediatric dosing, dose forms, and additives Highlights clinically important information (lab values to be monitored, patient education points, and safety information) Includes 30 appendix tables for quick access to key drug classifications, FDA pregnancy categories, Schedule of Controlled Substances, and more Provides generic/trade name cross reference

Download or read book The PA s Complete Guide to Prescribing Drug Therapy 2019 written by Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE and published by Springer Publishing Company. This book was released on 2018-04-28 with total page 857 pages. Available in PDF, EPUB and Kindle. Book excerpt: A quick-access guide to current drug recommendations with regular digital updates! Organized for speedy retrieval of vital information, this prescribing reference is designed for PAs and other advanced healthcare providers in all clinical practice settings. Available in print with ebook and regular digital updates, it guides practitioners involved in the primary care management of patients with acute, episodic, and chronic health problems in selecting appropriate pharmacology options and treatment regimens for over 500 diagnoses. Concise and easy to use, it is the only such resource organized by diagnosis, delivering drug choices alphabetically by generic name, with FDA pregnancy category, generic/over-the-counter forms, adult/pediatric dosing regimens, brand names, available dose forms, and additives. A helpful feature is the Comments interspersed throughout, offering such clinically useful information as laboratory values to monitor, patient teaching points, and safety information. Thirty appendices present information in table format, and an alphabetical cross-referenced index of drugs by generic and brand names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and safety during pregnancy. KEY FEATURES: Presents information in concise format for speedy drug information retrieval Organized by diagnosis in a consistent format that lists drug choices alphabetically by generic name, FDA pregnancy category, availability of generic and trade name, adult/pediatric dosing, dose forms, and more Highlights clinically important information such as lab values to be monitored, patient education points, and safety information Offers 30 tables providing ready access to key drug classifications, FDA pregnancy categories, Schedule of Controlled Substances, and many others Presents brand-generic cross reference Includes free ebook and regular updates with purchase

Download or read book The APRN and PA s Complete Guide to Prescribing Drug Therapy 2024 written by Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE and published by Springer Publishing Company. This book was released on 2024-02-15 with total page 843 pages. Available in PDF, EPUB and Kindle. Book excerpt: An unrivaled reference tool for advanced practice providers and students in clinical practice settings This concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice. The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. New to this Edition: Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases. Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma. Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populations Key Features: Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations. Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions. Serves advanced practice providers across the United States and internationally. Consistent with approvals and recommendations for use by the FDA.

Download or read book Davis s Drug Guide for Nurses written by April Hazard Vallerand and published by F.A. Davis. This book was released on 2020-05-18 with total page 1491 pages. Available in PDF, EPUB and Kindle. Book excerpt: Davis’s Drug Guide for Nurses®, Seventeenth Edition delivers all the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs

Download or read book Davis s Canadian Drug Guide for Nurses written by April Hazard Vallerand and published by F.A. Davis. This book was released on 2020-05-18 with total page 1491 pages. Available in PDF, EPUB and Kindle. Book excerpt: Davis’s Canadian Drug Guide for Nurses®, Seventeenth Edition delivers all the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs

Download or read book AURYXIA Drug Profile written by Drugpatentwatch and published by Independently Published. This book was released on 2023-08-11 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: AURYXIA (ferric citrate) drug patents, FDA exclusivity, litigation, drug prices

Download or read book NAPLEX 2017 Strategies Practice Review with 2 Practice Tests written by Amie D. Brooks and published by Simon and Schuster. This book was released on 2017-01-03 with total page 865 pages. Available in PDF, EPUB and Kindle. Book excerpt: Kaplan's NAPLEX Review is a step-by-step guide to scoring higher on the North American Pharmacist Licensure Examination. This fully updated book provides Kaplan's proven test-taking strategies, as well as expert review and guidance as you prepare for the exam.

Download or read book Dialysis Therapy written by Allen R. Nissenson and published by Lippincott Williams & Wilkins. This book was released on 1993 with total page 434 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive reference covering all aspects of the clinical management of adult and child dialysis patients. This edition includes seven new chapters including one on EPO use in dialysis patients and one on the HIV positive patient.

Download or read book FDA s Drug Review Process and the Package Label written by Tom Brody and published by Academic Press. This book was released on 2017-12-01 with total page 671 pages. Available in PDF, EPUB and Kindle. Book excerpt: FDA's Drug Review Process and the Package Label provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, Clinical Study Reports, and Investigator's Brochures. The book provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug. In detail, the book reproduces data on efficacy and safety from one hundred different FDA-submissions (NDAs, BLAs). The book reproduces comments and complaints from FDA reviewers regarding data that are fragmentary, ambiguous, or that detract from the drug's approvability, and the book reveals how sponsors overcame FDA's concerns and how sponsors succeeded in persuading FDA to grant approval of the drug. The book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely text and data from NDAs and BLAs, as published on FDA's website. The source material for writing this book included about 80,000 pages from FDA's Medical Reviews, FDA's Clinical Pharmacology Reviews, and FDA's Pharmacology Reviews, from one hundred different NDAs or BLAs for one hundred different drugs. Each chapter focuses on a different section of the package label, e.g., the Dosage and Administration section or the Drug Interactions section, and demonstrates how the sponsor's data supported that section of the package label. - Reveals strategies for winning FDA approval and for drafting the package label - Examples are from one hundred FDA-submissions (NDAs, BLAs) for one hundred different drugs, e.g., for oncology, metabolic diseases, autoimmune diseases, and neurological diseases - This book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely, the data from NDAs and BLAs as published on FDA's website at the time FDA grants approval to the drug

Download or read book Medication Therapy Management Second Edition written by Karen Lynn Whalen and published by McGraw Hill Professional. This book was released on 2018-04-05 with total page 654 pages. Available in PDF, EPUB and Kindle. Book excerpt: Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. Discover the medication therapy management solution—with this definitive, up-to-date sourcebook The need to improve the use of medications has major implications for the nation’s healthcare system. Burdened by high costs and an ineffective process of providing medication therapy, the current prescription drug environment poses considerable risks to patient safety. Medication therapy management (MTM) is designed to address these deficiencies—and this essential text gives pharmacists all the right MTM tools to identify and eliminate drug-related problems that can cause potentially severe adverse events. Medication Therapy Management delivers the most relevant insights into MTM—a vital service that is gaining momentum due to the rapid growth of patient-centered care, healthcare information technology, new practice models (e.g., Patient Centered Medical Home), and new payment methods. Cohesively organized, this expert-authored guide begins with an introduction to data sets for MTM, covering essential topics such as establishing quality and performance improvement, the payer perspective, conducting the comprehensive medication review, and reimbursement. The second part of Medication Therapy Management reviews MTM data sets for a wide spectrum of disorders, from asthma and atrial fibrillation to HIV and heart disease. Enhanced by the latest perspectives on therapeutics, including completely up-to-date tables throughout, Medication Therapy Management is a practical, skill-building roadmap for optimizing drug therapy and enhancing patient outcomes. Features • Everything you need to provide successful MTM services and empower patients to take an active role in their medication and overall healthcare • Turnkey disease-based data sets help you apply proven MTM principles to common disorders • Helpful appendices cover therapy management characteristics and answers to key questions; the MTM practice model and training survey; and the Medicare Part D MTM program standardized format

Download or read book Phosphate Metabolism written by Shaul Massry and published by Springer Science & Business Media. This book was released on 2013-11-21 with total page 611 pages. Available in PDF, EPUB and Kindle. Book excerpt: We present to our readers the proceedings of the Second International Workshop on Phosphate. A short account of the history of the effort led to the Phosphate Workshops is appro priate and can be of interest to the reader. The idea for Phosphate Workshops was born in the early days of November, 1974. One of us (S. G. M. ) suggested the thought to a group of scientists gathered for a luncheon in one of the attrac tive small restaurants in Weisbaden, Germany. The purpose of the workshop was to bring together interested scientists to discuss the newer developments and the recent advances in the field of phosphate metabolism and the other related minerals. An Organizing Committee made of Shaul G. Massry (USA), Louis V. Avioli (USA), Philippe Bordier (France), Herbert Fleisch (Switzerland), and Eduardo Slatopolsky (USA) was formed. The First Workshop was held in Paris during June 5-6, 1975 and was hosted by Dr. Philippe Bordier. Its proceeding was already published. The Second Workshop took place in Heidelberg during June 28-30, 1976 and was hosted by Dr. Eberhard Ritz. Both of these workshops were extremely successful scientific endeavors, and the need for them was demonstrated by the great interest they generated among the scientific community. The Or ganizing Committee, therefore, decided to continue with the tradi tion to hold additional Workshops annually or every other year.

Download or read book Orphan Drugs and Rare Diseases written by David Pryde and published by Royal Society of Chemistry. This book was released on 2014-07-30 with total page 487 pages. Available in PDF, EPUB and Kindle. Book excerpt: Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world’s population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.